» Articles » PMID: 8396673

Lymphocytes Protect Against and Are Not Required for Reovirus-induced Myocarditis

Overview
Journal J Virol
Date 1993 Oct 1
PMID 8396673
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Many studies suggest that host lymphocytes are damaging, rather than protective, in virally induced myocarditis. We have investigated the role of lymphocyte-based immunity in murine myocarditis by using a myocarditic reovirus (reovirus serotype 3 8B), nonmyocarditic reoviruses, adoptive transfer experiments, and mice with severe combined immunodeficiency (SCID mice). Prior to infection, passive transfer of monoclonal antibodies specific for 8B capsid proteins protected neonatal mice against 8B-induced myocarditis, indicating that humoral immunity can protect against myocarditis. Some monoclonal antibodies acted by blocking viral spread to and/or replication in the heart. Passive transfer of reovirus-immune, but not naive, spleen cells prior to infection protected neonatal mice from 8B-induced myocarditis. Depletion of either CD4 or CD8 T cells resulted in increased viral titer in the heart but did not abrogate immune cell-mediated protection against myocardial injury. This shows that both CD4 and CD8 T cells can act independently to protect myocardial tissue from reovirus infection. In addition, reovirus 8B caused extensive myocarditis in SCID mice. This confirms a prior report (B. Sherry, F. J. Schoen, E. Wenske, and B. N. Fields, J. Virol. 63:4840-4849, 1989) that T cells are not required for reovirus-induced myocarditis and demonstrates for the first time that B cells are not required for reovirus-induced myocarditis. We used SCID mice and a panel of reoviruses to assess (i) the relationship between growth in the heart and myocardial damage and (ii) the possibility that nonmyocarditic reoviruses exhibit a myocarditic phenotype in the absence of functional lymphocytes. Growth in the heart was not the sole determinant of myocarditic potential in SCID mice. Although 8B induced myocarditis in SCID mice, no or minimal myocarditis was found in SCID mice infected with four reovirus strains previously shown (B. Sherry and B. N. Fields, J. Virol. 63:4850-4856, 1989) to be nonmyocarditic or poorly myocarditic in normal neonatal mice. We conclude that (i) humoral immunity and cellular immunity are protective against, and not required for, reovirus-induced myocarditis and (ii) the potential to induce cardiac damage is a property of the virus independent of lymphocyte-based immunity.

Citing Articles

Spatiotemporal transcriptomics reveals pathogenesis of viral myocarditis.

Mantri M, Hinchman M, McKellar D, Wang M, Cross S, Parker J Nat Cardiovasc Res. 2023; 1(10):946-960.

PMID: 36970396 PMC: 10035375. DOI: 10.1038/s44161-022-00138-1.


The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis.

Zita M, Phillips M, Stuart J, Kumarapeli A, Snyder A, Paredes A J Virol. 2021; 96(2):e0187921.

PMID: 34757847 PMC: 8791294. DOI: 10.1128/JVI.01879-21.


The multi-functional reovirus σ3 protein is a virulence factor that suppresses stress granule formation and is associated with myocardial injury.

Guo Y, Hinchman M, Lewandrowski M, Cross S, Sutherland D, Welsh O PLoS Pathog. 2021; 17(7):e1009494.

PMID: 34237110 PMC: 8291629. DOI: 10.1371/journal.ppat.1009494.


Cell Killing by Reovirus: Mechanisms and Consequences.

McNamara A, Roebke K, Danthi P Curr Top Microbiol Immunol. 2020; 442:133-153.

PMID: 32986138 PMC: 11890104. DOI: 10.1007/82_2020_225.


Spontaneous activation of a MAVS-dependent antiviral signaling pathway determines high basal interferon-β expression in cardiac myocytes.

Rivera-Serrano E, DeAngelis N, Sherry B J Mol Cell Cardiol. 2017; 111:102-113.

PMID: 28822807 PMC: 5600710. DOI: 10.1016/j.yjmcc.2017.08.008.


References
1.
Ledbetter J, Herzenberg L . Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979; 47:63-90. DOI: 10.1111/j.1600-065x.1979.tb00289.x. View

2.
Walters M, LEAK P, JOSKE R, STANLEY N, PERRET D . MURINE INFECTION WITH REOVIRUS. 3. PATHOLOGY OF INFECTION WITH TYPES 1 AND 2. Br J Exp Pathol. 1965; 46:200-12. PMC: 2095271. View

3.
Wolfgram L, Beisel K, Rose N . Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med. 1985; 161(5):1112-21. PMC: 2187616. DOI: 10.1084/jem.161.5.1112. View

4.
Godeny E, Gauntt C . Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol. 1986; 137(5):1695-702. View

5.
Godeny E, Gauntt C . Murine natural killer cells limit coxsackievirus B3 replication. J Immunol. 1987; 139(3):913-8. View